The Impact of Original Antigenic Sin on Immunity Against Omicron
Written on
Chapter 1: Understanding Original Antigenic Sin
Research from the late 20th century uncovered a significant immune phenomenon where antibodies formed against one strain of the influenza virus continued to react even when exposed to a different strain. While these older antibodies fail to effectively combat the new strain, they can also obstruct the development of more suitable antibodies. This behavior is termed original antigenic sin or immune imprinting.
As SARS-CoV-2 has evolved from its initial 2019 Wuhan variant into various strains—Alpha, Beta, Gamma, Delta, and now Omicron—scientists have raised concerns about the possible emergence of original antigenic sin. Recent evidence has emerged supporting this theory, shedding light on how Omicron has rapidly outpaced other variants that were previously dominant.
Section 1.1: Insights from Recent Research
A pivotal study titled “Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure,” published in Science, investigated the immune responses of 731 healthcare workers who were either vaccinated or infected with different SARS-CoV-2 variants.
The findings revealed that among individuals who had received three vaccine doses, those with previous infections from the Wuhan or Delta variants experienced a more significant decline in antibody and T-cell responses to Omicron than those who had never been infected. Additionally, among those vaccinated and subsequently infected with Omicron, individuals without prior infections exhibited stronger immune responses compared to those previously infected with the Wuhan variant.
Thus, prior infections may impair the immune response to subsequent variants in fully vaccinated individuals.
Subsection 1.1.1: Longitudinal Immune Response Analysis
The study also tracked immune responses over time. Among those with a single vaccine dose, individuals with a history of infection showed better antibody responses to Omicron compared to those without past infections, indicating a hybrid immunity effect. However, this hybrid advantage appeared to dissipate among those with two or three vaccine doses, where both groups exhibited similar responses to Omicron.
Crucially, after 14 weeks during the Omicron surge, individuals with prior Wuhan infections exhibited diminished antibody responses against Omicron compared to those who had only been vaccinated and subsequently infected with Omicron. This suggests that prior Wuhan variant infections might hinder the immune response against Omicron due to immune imprinting.
Section 1.2: Comparative Studies on Antibody Efficacy
Another relevant study, “Imprinted antibody responses against SARS-CoV-2 Omicron sublineages,” published as a preprint and later in Science, examined the efficacy of antibodies from various groups. The researchers found that over 80% of antibodies from vaccinated individuals who experienced breakthrough infections reacted more with older SARS-CoV-2 variants. Conversely, unvaccinated individuals who contracted Omicron produced a higher proportion of Omicron-specific antibodies.
This could be misinterpreted as suggesting that vaccination increases vulnerability to Omicron. However, prior studies affirm that current vaccines still provide protection against Omicron-related illness.
As the researchers noted, “These findings illustrate how immunological imprinting from prior exposure, i.e., ‘original antigenic sin’, can strongly affect the response to antigenically novel antigens.” This underscores how infection with Omicron may preferentially enhance existing B cell responses primed by vaccination, contributing to the concept of immunological imprinting.
Chapter 2: Implications of Immunological Findings
The evidence suggests that most individuals possess some level of immunity against Covid-19, whether vaccinated or not. Given the widespread nature of SARS-CoV-2, even unvaccinated individuals likely encountered the virus at some point. The compromised immune responses to Omicron may elucidate its unprecedented dominance over previous variants like Alpha and Delta.
Moreover, Omicron's ability to evade the immune response further facilitates its prevalence. The authors of the studies indicate that the high global spread of Omicron infections likely reflects significant immune evasion at multiple levels, compounded by the effects of original antigenic sin.
However, it’s important to note that the findings are primarily derived from laboratory studies, which may not directly correlate with real-world immunity. As Dr. Deepti Gurdasani emphasized, understanding the implications of these findings on protection against infection and severe disease is crucial.
In conclusion, while hybrid immunity may seem advantageous, it’s essential to recognize the potential risks of infections in terms of long COVID and diminished responses to future variants.
If you found this discussion enlightening, feel free to subscribe to my Medium email list for more insights. You can also support my work through my referral link for Medium membership or by leaving a tip.